Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 3/20 | 0.67 |
| ▸ | ALOX5 | P09917 | 6/20 | 0.62 |
| ▸ | QDPR | P09417 | 3/20 | 0.56 |
| ▸ | SNCA | P37840 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.46 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.46 |
| ▸ | PPM1B | O75688 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL338028 | 0.82 | APP (1.00) | APPALOX5QDPRSNCACYP3A4 | |
| SCHEMBL5493701 | 0.80 | APP (0.41) | APPALOX5QDPRSNCACYP3A4 | |
| SCHEMBL3814886 | 0.77 | ALOX5 (1.00) | APPALOX5QDPRSNCA | |
| SCHEMBL1235644 | 0.77 | ALOX5 (1.00) | APPALOX5QDPRSNCA | |
| SCHEMBL30016853 | 0.77 | APP (0.90) | APPALOX5QDPRCYP3A4ALOX15 | |
| SCHEMBL27922800 | 0.77 | HSD17B1 (0.55) | CYP3A4 | |
| SCHEMBL12084357 | 0.76 | APP (0.88) | APPALOX5QDPRSNCACYP3A4 | |
| SCHEMBL1510280 | 0.76 | ACMSD (0.70) | CYP3A4PPM1B | |
| SCHEMBL3987934 | 0.76 | ALDH1A1 (0.44) | APPCYP3A4ALOX15HSD17B10 | |
| SCHEMBL208526 | 0.76 | ALDH1A1 (0.35) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345986-A1 | CONJUGATED DIYNES AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2023-11-02 | — | — | US | disclosed |
| CN-114468199-A | Conjugated diynes and their use as flavor modifiers | 弗门尼舍有限公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-108147983-A | A kind of sulfosalt bonding benzene polyphenol type molecular glass photoresist and its preparation method and application | 中国科学院化学研究所 | 2018-06-12 | — | — | CN | disclosed |
| US-8105636-B2 | Compositions and methods for treating inflammation and inflammation-related disorders by Plectranthus amboinicus extracts | ACADEMIA SINICA (TW) | 2012-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230345986-A1 | CONJUGATED DIYNES AND THEIR USE AS FLAVOR MODIFIERS | ARGLU1, PRMT6, PRMT3 | APP 4835/4885ALOX5 2457/4885QDPR 340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.